We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+0.86%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.9B
AUM Growth
+$1.29B
(+3%)
Cap. Flow
+$573M
Cap. Flow
% of AUM
1.31%
Top 10 Holdings %
Top 10 Hldgs %
9.28%
Holding
3,471
New
479
Increased
1,205
Reduced
1,169
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$229M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$212M |
| 3 |
Snowflake
SNOW
|
+$211M |
| 4 |
Lam Research
LRCX
|
+$193M |
| 5 |
CME Group
CME
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$282M |
| 2 |
PepsiCo
PEP
|
+$239M |
| 3 |
Walmart Inc
WMT
|
+$236M |
| 4 |
General Motors
GM
|
+$223M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.57% |
| 2 | Healthcare | 13.05% |
| 3 | Financials | 12.83% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
Nexa Resources
NEXA
$2.01B
| $78.5K | ﹤0.01% |
10,272
-3,426
| -25% | -$25.8K |
|
2802
Humacyte Inc Warrant
HUMAW
$20.5K
| $77.5K | ﹤0.01% |
55,767
+34,118
| +158% | +$42.3K |
|
2803
Genelux
GNLX
$124M
| $77.4K | ﹤0.01% |
+39,715
| New | +$135K |
|
2804
Kosmos Energy
KOS
$1.7B
| $76.6K | ﹤0.01% |
+13,833
| New | +$80.7K |
|
2805
Precigen
PGEN
$2.55B
| $76.3K | ﹤0.01% |
48,315
-15,937
| -25% | -$23.1K |
|
|
CLLS
2806
Cellectis
CLLS
$322M
| $75.3K | ﹤0.01% |
40,289
-9,591
| -19% | -$25.2K |
|
|
LILM
2807
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $74.5K | ﹤0.01% |
93,717
-47,324
| -34% | -$44.4K |
|
|
MAXN
2808
DELISTED
Maxeon Solar Technologies
MAXN
| $74.3K | ﹤0.01% |
871
-2,777
| -76% | -$588K |
|
|
LGVN
2809
Longeveron
LGVN
$26.7M
| $74.1K | ﹤0.01% |
+46,041
| New | +$80.5K |
|
|
MAPS
2810
DELISTED
WM TECHNOLOGY INC A
MAPS
| $72.3K | ﹤0.01% |
69,541
+2,100
| +3% | +$2.31K |
|
2811
KVH Industries
KVHI
$138M
| $72.1K | ﹤0.01% |
+15,500
| New | +$77.3K |
|
|
HOOK
2812
DELISTED
HOOKIPA Pharma
HOOK
| $71.9K | ﹤0.01% |
12,147
+2,671
| +28% | +$21.2K |
|
2813
Rallybio
RLYB
$89M
| $71.4K | ﹤0.01% |
+6,657
| New | +$90.2K |
|
2814
Red Cat Holdings
RCAT
$1.35B
| $68.4K | ﹤0.01% |
+59,518
| New | +$64.1K |
|
|
SRG
2815
Seritage Growth Properties
SRG
$119M
| $68.1K | ﹤0.01% |
14,587
-149,521
| -91% | -$1.09M |
|
2816
American Well
AMWL
$201M
| $66.2K | ﹤0.01% |
10,198
+8,196
| +409% | +$82.5K |
|
|
TVRD
2817
Tvardi Therapeutics
TVRD
$23.7M
| $65.6K | ﹤0.01% |
7,060
-662
| -9% | -$15.8K |
|
|
RPT
2818
Rithm Property Trust
RPT
$102M
| $65.4K | ﹤0.01% |
3,055
-3,039
| -50% | -$64.8K |
|
2819
Lightwave Logic
LWLG
$899M
| $65.2K | ﹤0.01% |
+21,791
| New | +$79.6K |
|
2820
China Automotive Systems
CAAS
$145M
| $65K | ﹤0.01% |
18,309
-195
| -1% | -$717 |
|
2821
Imperial Petroleum
IMPP
$239M
| $63.8K | ﹤0.01% |
16,431
-954
| -5% | -$3.53K |
|
|
RGLS
2822
DELISTED
Regulus Therapeutics
RGLS
| $63K | ﹤0.01% |
+35,299
| New | +$81.9K |
|
2823
NN Inc
NNBR
$304M
| $63K | ﹤0.01% |
20,995
-23,659
| -53% | -$82.8K |
|
|
TRVG
2824
trivago
TRVG
$395M
| $61.5K | ﹤0.01% |
30,572
-29,723
| -49% | -$71.3K |
|
2825
Xeris Biopharma Holdings
XERS
$1.6B
| $60.3K | ﹤0.01% |
26,803
-103,061
| -79% | -$208K |
|
Similar funds
John Overdeck's Q2 2024 Portfolio in Review
As of Q2 2024, John Overdeck held 3,471 positions worth $43.9B, up 3% from $42.6B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
John Overdeck's Q2 2024 filing shows 479 new, 1,205 increased, 1,169 reduced and 480 closed positions. Its largest new stake was Accenture: 270,632 shares worth $82.1M. The largest sale was Alphabet (Google) Class A, an estimated $282M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q2 2024 buy was Accenture: 270,632 shares worth $82.1M.
- John Overdeck added most to Advanced Micro Devices in Q2 2024, an estimated $229M increase.
- John Overdeck's biggest Q2 2024 reduction was Alphabet (Google) Class A, cutting an estimated $282M.
- John Overdeck fully exited State Street Communication Services Select Sector SPDR ETF in Q2 2024, selling an estimated $186M.
- John Overdeck's ten largest holdings make up 9.3% of its $43.9B portfolio in Q2 2024.
- John Overdeck opened 479 new positions and closed 480 in Q2 2024.
- John Overdeck's portfolio value rose 3% quarter-over-quarter to $43.9B.
Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.